Latanoprost

拉坦前列素

Report date: 2026/04/09 20:00:21
NME

Base Information

Drug NameLatanoprost
Drug Alias Name拉坦前列腺素LatanoprostumMicroProstCatioprostMonoprost +[22] 
ClassificationSmall molecules
Mechanisms of ActionProstanoid FP receptor agonists
TargetsProstanoid FP receptor
Therapy Area/IndicationsVitiligoAlopecia AreataGlaucoma, Open-Angle +[8] 
Global Approved IndicationsGlaucoma, Open-AngleOcular Hypertension
Approved Indications in ChinaGlaucoma, Open-AngleOcular Hypertension
Original Approved Country/TerritoryUnited States
Original Approved Date1996/06/05
Country/TerritoryCzechiaBelgiumCanada +[36] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesUpjohn IncEgymedicalpediaSanten Sas +[10] 
Inactive CompaniesNephron Pharmaceuticals CoViatrisLaboratoires Thea SAS +[10] 
Active IndicationsVitiligoAlopecia AreataGlaucoma, Open-Angle +[6] 
Inactive IndicationsEye DiseasesMeniere Disease

Other Information

ATC CodeS01EE01
Related LinksWikipediaDrugBankKEGG